Role of the complement system in antibody-dependent enhancement of flavivirus infections.
Antibody dependent enhancement
C1q
Complement
Dengue virus
Flavivirus
West Nile virus
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
06
07
2020
revised:
10
12
2020
accepted:
13
12
2020
pubmed:
23
12
2020
medline:
5
5
2021
entrez:
22
12
2020
Statut:
ppublish
Résumé
Flavivirus infections have increased dramatically in the last decades in tropical and subtropical regions of the world. Antibody-dependent enhancement of dengue virus infections has been one of the main hypotheses to explain severity of disease and one of the major challenges to safe and effective vaccine development. In the presence of cross-reactive sub-neutralizing concentrations of anti-dengue antibodies, immune complexes can amplify viral infection in mononuclear phagocytic cells, triggering a cytokine cascade and activating the complement system that leads to severe disease. The complement system comprises a family of plasma and cellular surface proteins that recognize pathogen associated molecular patterns, modified ligands and immune complexes, interacting in a regulated manner and forming an enzymatic cascade. Pathogenic as well as protective effects of complement have been reported in flavivirus infections. This review provides updated knowledge on complement activation during flavivirus infection, including antiviral effects of complement and its regulation, as well as mechanisms of complement evasion and dysregulation of complement activity during viral infection leading to pathogenesis. Particularly, insights into classical pathway activation and its protective role on antibody-dependent enhancement of flavivirus infections are highlighted.
Identifiants
pubmed: 33352325
pii: S1201-9712(20)32562-5
doi: 10.1016/j.ijid.2020.12.039
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
404-411Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.